Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,651   4.84  Index Moved Down -0.29%
NVO TEVA AGN FRX Railroads Synthetics ISP Drugs 
United States GSPC USD ...  |  Investing Opportunities


Processing
Collecting data for POZN

POZEN quote and profile

 
 Companies |  Insiders  | Dashboard  
     
4.93
  
STOCK
0.03  Macroaxis: 0.61 Up   0.61%  
Year To Date
4.558.12
Last 1 Month(s)
4.55.15
Trading Day 
4.895.02
May 23 2013 

Diversification Suggestion

Use POZEN to enhance returns of your portfolios. The stock experiences moderate upward volatility
Analyze POZEN Inc Trend or Check current 30 days POZEN correlation with market (S&P 500)
1 Month Beta 1.81  
Highest Price:  
Lowest Price:  
5.15  
4.5  
April 23 2013 
May 13 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, POZEN will likely underperform.
POZEN Inc Large BetaPOZEN Inc Beta Legend
POZN United States Nasdaq
POZEN Inc
Healthcare
Drug Manufacturers - Other
Benchmark S&P 500
http://www.pozen.com
Contact Number: 919. 913. 1030
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation66.24 M
Shares Outstanding30.35 M
Number of Shares Shorted1.67 M
Revenue5.35 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen POZN POZN agains markets  0.61 % Macroaxis: 0.61 Moved Up  
 
 United States Russel   0.21 % Macroaxis: 0.21 Moved Up  
 
 United States SP 500   0.29 % Macroaxis: 0.29 Moved Down  
 
 United States NYSE   0.44 % Macroaxis: 0.44 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

POZEN Leadership

John Plachetka Chairman of the Board and Presidentident, CEO, Ph.D
John D Co-Founder, Chairman, CEO and Pres
William Hodges CFO, Senior Vice President - Finance and Administration
Tomas Bocanegra Executive Vice President - Development, Ph.D

POZEN Price and Market Media

The median price of POZEN for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 4.91 with a coefficient of variation of 3.42. The daily time series for the period is distributed with a sample standard deviation of 0.17, arithmetic mean of 4.87, and mean deviation of 0.12. The Stock received substential amount of media coverage during this period.
POZEN         SP 500
Price Growth (%)
 
1
Hedgies Aren39t Crazy About POZEN Inc.04/26/2013Macroaxis: News
2
Maybe We Shouldn39t All Be Eating Lunch At Our Desks05/02/2013Macroaxis: News
3
Stocks Views and Recommendations CSPI AXLL POZN CA05/10/2013Macroaxis: News
4
Presence of Gastric Erosions in Patients Taking LowDose Aspi...05/22/2013Businesswire News

POZEN Summary

POZEN Inc [POZN] is traded on NASDAQ in USA. It is located in Chapel Hill, NC and employs 29 people. The company currently falls under 'Small-Cap' category with current market capitalization of 151.73 M. POZEN Inc conducts business under Healthcare sector and is part of Drug Manufacturers - Other industry. This company has 30.35 M outstanding shares of which 1.67 M shares are at this time shorted by private and institutional investors with about 4.9 trading days to cover.
POZEN Inc., a pharmaceutical company, develops solutions for the treatment of acute and chronic pain, and pain related conditions in the United States. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
More
Than
78 %
 
Follow POZEN with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add POZEN to your reader
 

POZEN Research Report

POZEN vs. Novo

Correlation analysis and fundamentals comparison between POZEN Inc and Novo Nordisk A-S

POZEN Executives

William CPA CFO and Sr. VP of Fin. and Admin.

POZEN Directors

Jacques Rejeange Independent Director
Arthur Kirsch Independent Director
Seth Rudnick Independent Director
Martin Nicklasson Independent Director
Neal Fowler Independent Director

POZEN Management

Elizabeth Cermak Chief Commercial Officer and Executive VP, MBA
Gilda JD Sr. VP, General Counsel and Secretary
John Fort Chief Medical Officer

POZEN Fundamentals

Price to Sales vs Operating Margin
Net Income vs Cash per Share
Price to Sales vs Return On Equity
Short Ratio vs Cash per Share

POZEN vs Competition

POZEN vs. Novo Nordisk A-S
POZEN vs. Teva Pharmaceutical Industries Limited
POZEN vs. Allergan Inc
POZEN vs. Forest Laboratories Inc
POZEN vs. Dr Reddys Laboratories Ltd
POZEN vs. Pharmacyclics Inc
POZEN vs. Warner Chilcott plc
POZEN vs. Endo Health Solutions Inc
POZEN vs. Cubist Pharmaceuticals Inc
POZEN vs. United Therapeutics Corporation

POZEN May 23 2013 Opportunity Range

Downside Deviation2.5
Information Ratio(0.18)
Maximum Drawdown8.06
Value At Risk(3.50)
Potential Upside3.13

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium